| More

Tissue distribution and depletion of levamisole in sheep tissues

Views: 311 Downloads: 251
A. E. TYRPENOU (Α.Ε.ΤΥΡΠΕΝΟΥ), E. M. XYLOURI-FRANGIADAKI (Ε.Μ. ΞΥΛΟΥΡΗ-ΦΡΑΓΚΙΑΔΑΚΗ), G. M. FRANGIADAKIS (Μ.Γ. ΦΡΑΓΚΙΑΔΑΚΗΣ)
A. E. TYRPENOU (Α.Ε.ΤΥΡΠΕΝΟΥ), E. M. XYLOURI-FRANGIADAKI (Ε.Μ. ΞΥΛΟΥΡΗ-ΦΡΑΓΚΙΑΔΑΚΗ), G. M. FRANGIADAKIS (Μ.Γ. ΦΡΑΓΚΙΑΔΑΚΗΣ)

Abstract


The subject-matter of this project was the residue distribution and depletion of levamisole in the sheep tissues after a single administration of levamisole hydrochloride and with final aim the appropriate withdrawal time determination, so that sheep tissues will be safe for human consumption. Levamisole hydrochloride was given per os with a single dose in the form of a tablet of the pharmaceutical product Tridicine™ 300 mg at the recommended therapeutic dose of 300 mg/40 kg body weight (b.w.), a quantitycorresponding to 7.5 mg levamisole per kg b.w. Five sampling points comprised of four sheep each one , were performed at 24 h, 96 h, 168 h, 240 h and 336 h after medication. Tissue samples of muscle, liver, kidney and fat were collected, packed and stored at 45°C until analysis. Levamisole was determined by high performance liquid chromatography (HPLC) and mean levamisole concentrations found in the target tissues were detectable in all samples from the 1st until the 14th day after medication, with higher concentrations in kidney and liver ranging from 838.88 μg/kg to 39.18 μg/kg and from 1988.77 μg/kg to 16.58 μg/kg between the 1st and the 14th day, respectively. Concentrations in muscle and fat, the 1st day after medication, were 233.96 μg/kg and 173.89 μg/kg, respectively and the 4th day they were dropped below the maximum residue limit (MRL), which means that sheep tissues are safe for the consumer. A withdrawal time of 13 days was determined for liver, the main organ used for this calculation.


Keywords


Levamisole; residues; sheep tissues; depletion; withdrawal time

Full Text:

PDF

References


Braund KG (2003) Neurotoxic Disorders. In: Braund, K.G. (Ed), Clinical Neurology in Small Animals-Localization, Diagnosis and Treatment. International Veterinary Information Service

(www.ivis.org), Ithaca, New York, USA, pp 1-23.

Chankvetadzea B, Burjanadze N, Santi M, Massolini G, Blaschke G (2002). Enantioseparation of tetramisole by capillary electrophoresis and high performance liquid chromatography and application of these techniques to enantiomeric purity determination of a veterinary drug formulation of L-levamisole. J Sep Sci, 25:733-740.

Cherlet M, de Baere S, Croubels S, de Backer Ρ (2000) Quantitative analysis of levamisole in porcine tissues by high-performance liquid chromatography combined with atmospheric pressure

chemical ionization mass spectrometry. J Chromatogr B, 742:283-293.

COMMISSION REGULATION (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin. Official Journal of the European Communities L 60/16 9. 3. 1999.

Dolezalova M, Tkaczykova M (2001) LC determination of the enantiomeric purity of levamisole using stationary phase with bonded naphthylethylcarbamoylated-beta-cyclodextrin. J Pharm Biomed Anal, 25:407-415.

EMEA (<1995) EMEA Levamisole-Summary (2). Committee for Veterinary Medicinal Products. The European Agency for the Evaluation of Medicinal Products. Veterinary Medicines Evaluation Unit.

EMEA (1995) EMEA, Note for Guidance: Approach towards harmonisation of withdrawal times. The European Agency for the Evaluation of Veterinary Medicinal Products. EMEA/MRL/036/95-Final.

Hekman Ρ (2004) BRD Agency for the Registration of Veterinary Medicinal Products, The Netherlands, pp 1-8.

IPCS (1991) IPCS-Levamisole. In: Toxicological evaluation of certain veterinary drug residues in food. The thirty-sixth meeting of the joint FAO/WHO expert committee on food additives (JECFA).

WHO Food additives series: 27. International Programme on Chemical Safely. World Health Organization, Geneva, pp 75-101.

Kindred T, Walcott J (1996) The FSIS National Residue Programme. In: Haagsma N, Ruiter A (Eds), Proceedings of the EuroResidue III conference on Residues of Veterinary Drugs in Food,

COLOPHON, Veldhoven, The Netherlands, pp 175-184.

McKellar QA (1997) Ecotoxicology and residues of anthelminthic compounds. Vet Parasitol, 72:413-435.

Palermo D , Milillo MA (1979) Gas-chromatographic determination of levamisole residues in sheep flesh. Boll Soc Ital Biol Sper, 55:1859-1862.

Paulson GD, Feil VJ (1996) The disposition of 14C-levamisole in the lactating cow. Xenobiotica 26:863-875.

Rose MD, Argent LC, Shearer G, Farrington WHH (1995) The effect of cooking on veterinary drug residues in food: 2. levamisole. Food Addit Contam 12:185-194.

Sahagun AM, Teran MT, Garcia JJ, Fernandez N, Sierra M, Diez MJ (2001) Oral bioavailability of levamisole in goats. J Vet Pharmacol Ther, 24:439-442.

Tyrpenou AE, Xylouri-Frangiadaki EM (2006) Determination of Levamisole in Sheep Muscle Tissue by High-Performance Liquid Chromatography and Photo Diode Array Detection. Chromatographia 63:321-326.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 A. E. TYRPENOU (Α.Ε.ΤΥΡΠΕΝΟΥ), E. M. XYLOURI-FRANGIADAKI (Ε.Μ. ΞΥΛΟΥΡΗ-ΦΡΑΓΚΙΑΔΑΚΗ), G. M. FRANGIADAKIS (Μ.Γ. ΦΡΑΓΚΙΑΔΑΚΗΣ)